Stephen is a founder of the George Institute for Global Health and an architect of its global expansion. He is Principal Director of the George Institute and also holds professorial appointments in medicine at UNSW Sydney and the University of Oxford (UK), where he holds the position Oxford Martin Senior Fellow.
He is an international authority on the causes, prevention and treatment of cardiovascular diseases and has a special interest is the clinical management of chronic and complex conditions in resource-poor settings, particularly in the Asia-Pacific region. For his work in the field of cardiovascular disease, he has received numerous awards, fellowships and honours from governments, universities and learned societies worldwide.
Stephen founded George Clinical in 2008 as an initiative designed to provide high-quality clinical research services and scientific leadership to the pharmaceutical and medical technology industries. George Clinical is now part of George Health Enterprises, which was established by Stephen in 2013 as the Institute’s commercial arm, comprising three aligned businesses focussed on healthcare in emerging markets. Stephen was named EY Social Entrepreneur of the Year in 2013.